@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP657102.RAogWk2XuKqMck17v4DPbqAFtnBWLU_a19bG-vjWsNpL8130_head { this: np:hasAssertion dgn-np:NP657102.RAogWk2XuKqMck17v4DPbqAFtnBWLU_a19bG-vjWsNpL8130_assertion; np:hasProvenance dgn-np:NP657102.RAogWk2XuKqMck17v4DPbqAFtnBWLU_a19bG-vjWsNpL8130_provenance; np:hasPublicationInfo dgn-np:NP657102.RAogWk2XuKqMck17v4DPbqAFtnBWLU_a19bG-vjWsNpL8130_publicationInfo; a np:Nanopublication . dgn-np:NP657102.RAogWk2XuKqMck17v4DPbqAFtnBWLU_a19bG-vjWsNpL8130_assertion a np:Assertion . dgn-np:NP657102.RAogWk2XuKqMck17v4DPbqAFtnBWLU_a19bG-vjWsNpL8130_provenance a np:Provenance . dgn-np:NP657102.RAogWk2XuKqMck17v4DPbqAFtnBWLU_a19bG-vjWsNpL8130_publicationInfo a np:PublicationInfo . } dgn-np:NP657102.RAogWk2XuKqMck17v4DPbqAFtnBWLU_a19bG-vjWsNpL8130_assertion { miriam-gene:930 a ncit:C16612 . lld:C0522274 a ncit:C7057 . dgn-gda:DGN1a188a3ec1c475a63c3ebef12642a76a sio:SIO_000628 miriam-gene:930, lld:C0522274; a sio:SIO_001121 . } dgn-np:NP657102.RAogWk2XuKqMck17v4DPbqAFtnBWLU_a19bG-vjWsNpL8130_provenance { dgn-np:NP657102.RAogWk2XuKqMck17v4DPbqAFtnBWLU_a19bG-vjWsNpL8130_assertion dcterms:description "[Factors associated with lower CD19+ B cell levels were as follows: aGVHD grades II-IV had a trend to affect CD19+ B cell reconstitution at +180 days; clinically extensive cGVHD was significantly associated with CD19+ B cell deficiency at +360 days and serum IgG level at +180 and +360 days; cytomegalovirus (CMV) infection occurred after +38 days was correlated with lower B cell level at both +90 and +360 days, while those occurred before +38 days did not show this effect; glucocorticoids used around +90 and +180 days was associated with lower CD19+ B cell levels at +90 and +360 days, respectively, especially in patients that did not experience extensive cGVHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:22674381; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP657102.RAogWk2XuKqMck17v4DPbqAFtnBWLU_a19bG-vjWsNpL8130_publicationInfo { this: dcterms:created "2014-10-02T12:38:35+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }